Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.

Kering (ENXTPA:KER) has drawn fresh attention after Gucci signed a fifty year exclusive beauty license with L’Oréal, shifting future fragrance and cosmetics development and distribution to the French beauty group.

See our latest analysis for Kering.

The Gucci beauty deal arrives at a time when Kering’s share price is under pressure, with a 1-day share price return of 2.57% contrasting with a year to date share price decline of 19.30% and a 3-year total shareholder return that is down 46.52%. Overall, short term share price momentum looks weak while the 1-year total shareholder return of 20.91% highlights how volatile the stock’s recovery efforts have been.

If this kind of brand partnership has you thinking more broadly about where growth stories might emerge next, it could be worth scanning 108 top founder-led companies

Bulls see the Gucci beauty handover as a reset that the recent share price slide has not fully captured, while bears focus on volatility and a recent loss. Which case is closer to what Kering’s valuation suggests next?

Most Popular Narrative: 13% Undervalued

Kering’s most followed narrative points to a fair value of about €282 per share, above the last close at €245.80, centering the debate on how sustainable cash generation could support that gap.

The analysts have a consensus price target of €282.46 for Kering based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €360.0, and the most bearish reporting a price target of just €175.0.

Read the complete narrative.

Want to see what justifies that valuation spread for Kering? The narrative leans on a turn from losses to solid earnings, plus expanding margins and revenue assumptions that reshape its future profit profile.

Result: Fair Value of €282 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, the Kering narrative could be knocked off course if prolonged revenue pressure across key brands or weaker tourism demand continues to weigh on margins and cash generation.

Find out about the key risks to this Kering narrative.

Another View on Kering’s Valuation

While the analyst narrative frames Kering as about 13% undervalued versus a fair value of roughly €282 per share, the SWS DCF model points to a different outcome, with an estimate of €237.37 compared with the current €245.80 share price, which looks slightly overvalued instead.

That gap between a DCF that leans cautious and a higher fair value from analyst assumptions raises a simple question for you: which set of cash flow expectations feels more realistic for Kering over the next few years?

Look into how the SWS DCF model arrives at its fair value.

KER Discounted Cash Flow as at Jul 2026 KER Discounted Cash Flow as at Jul 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kering for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 213 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

Next Steps

Kering’s mix of pressure points and potential rewards has been front and center, so it makes sense to review the numbers yourself and move quickly to shape your own view with the help of 1 key reward and 1 important warning sign

Looking for more investment ideas beyond Kering?

If Kering has sharpened your focus, do not stop here. Some of the most compelling opportunities often sit just outside your current watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include KER.PA.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com